TOLIFE will clinically validate an artificial intelligence (AI) solution to process daily life patient data captured by unobtrusive sensors to enable optimised personalised treatment, assessment of health outcomes and improved quality of life in chronic obstructive pulmonary disease patients. The TOLIFE approach to chronic obstructive pulmonary disease management, targeted to predict and mitigate exacerbations and continuously assess the health outcomes, has the potential to reduce mortality, improve health related quality of life and reduce the healthcare costs.
Video Progetto "ToLife"
Mirko Passera;Elisabetta Pisano;Chiara Benvenuti;Michele Zanoletti;Pasquale Bufano;Marco Laurino
2023
Abstract
TOLIFE will clinically validate an artificial intelligence (AI) solution to process daily life patient data captured by unobtrusive sensors to enable optimised personalised treatment, assessment of health outcomes and improved quality of life in chronic obstructive pulmonary disease patients. The TOLIFE approach to chronic obstructive pulmonary disease management, targeted to predict and mitigate exacerbations and continuously assess the health outcomes, has the potential to reduce mortality, improve health related quality of life and reduce the healthcare costs.File in questo prodotto:
Non ci sono file associati a questo prodotto.
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
